IL6 and cancer: Furthermore, studies that encompass disease behavior in animal experiments, as well as cancer symptom clusters in humans, support the hypothesis that pro-inflammatory cytokines are one of the biological mechanisms underlying the emergence of these symptom clusters, especially the release of IL-1β, IL-6, IL-8, TNF-α, IL-12p70 and IFN-y(6-8,11).